chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Took vaccine 12/21/2020 12/22/20 Slight sore throat, injection site barely sore (left arm) 12/23/20 AM:slight sore throat, discomfort, pain left axilla PM:sore throat gone, pain under left axilla with sore/swollen Lymph Node (golf ball size) 12/24/20 All day: Pain left arm and under left axilla with sore/swollen Lymph Node (golf ball size), swollen Lymph Node left subclavicular, overall feeling of unwell, headache, nausea, hurts to breath deep. No appetite. Fever 99.8 Feel worse than when I had Covid.  12/25/20 AM: Didn?t sleep well, symptoms same as 12/24 with additional swollen and painful Lymph Nodes on left side of neck  (pea size), no fever PM: Feeling some better, less pain, Lymph Nodes still swollen, no fever 12/26/20 Feeling better other than Lymph Nodes (still swollen and axilla still sore) 12/27/20 Continuing to feel better, still swollen Lymph nodes less sore
About 25-30 red papular bumps over trunk, arms and face. To give Benadryl and use Calamine lotion.
Information has been received from a Registered Nurse (R.N.) concerning a female patient who was vaccinated with a first dose of Gardasil. The nurse reported "patient developed nausea, vomitting, dizziness, and chills." Unspecified medical attention was sought by the patient. The outcome was unknown. Additional information has been requested.
patient mom states daughters hair began falling out in excess. she showed me pictures it did indeed look like a lot of hair to come out at once. hair continued to come out over the coarse of the following days. patient received vaccine 5 days ago.
Suspected Vaccination Failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient himself or herself. The age at vaccination was not reported. The patient stated that the he/she received shingles shot and experienced shingles 2 times. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided.
Information has been received from a registered nurse regarding a patient of unknown age and gender. On 03-MAR-2013 at 11:30 ZOSTAVAX (Lot # 672476/16055AA) was exposed to -12 degrees C for an estimated total time out of range of 4 hours. On 22-MAR-2012, the patient was vaccinated with an out of range dose of ZOSTAVAX (Lot # 672476/1605AA, expiration date 13-JAN-2013) (dose and route of administration were not provided). No adverse experience was reported. This is one of 182 reports received from the same source. Additional information has been requested.
AFTER RECEIVING JANSSEN COVID VACCINE, PT WAS TOLD TO SIT DOWN FOR 15 MINUTES. HER FIANCE NOTICED SHE WAS DIZZY AND SHOUTED FOR HELP. AFTER FEW MINUTES PT WAS AWARE OF WHAT WAS GOING ON, BUT WANTED TO CALL 911 (AND EMS) ARRIVED AND CHECK HER VITALS. SHE WAS RELEASED TO GO HOME AND REST AFTERWARDS.
3RD DOSE MODERNA COVID VACCINE GIVEN 11/11/21, #058F21A; 8/3/22 pt admitted from a rehab center for pneumonia and UTI; on ABX; during hospital course, pt found to be positive for COVID on 8/12/22; Remdesivir x 3days; weaned off of O2; dc'd back to rehab for PT on 8/17/22; pt passed away at home on 9/8/22
Patient experienced dizziness, nausea, and numbness in her arm following her vaccination during the 15 minute observation period. She was assisted to the floor to lay down on her back and elevate her feet. We applied cold compress to her neck and she began to feel better within a few minutes and was able to return to a seated position with symptoms resolving back to normal within 30 minutes.
Pt presented to the clinic on 02/06 with complaints of generalized aching, malaise, and poor appetite. Returned to clinic on 02/07 with same symptoms, WBC 22,000, started on Levaquin and Flagyl. On 02/08 reported fever the night before of 101, WBC 24,000 and was admitted to hospital. Pt did have a urinary tract infection, as well.
Has undiagnosed mild dementia.  He received his first shot at 5:30 p.m. on 1/20/2021 with no ill effects.  But on 1/22/2021 about 12:30 p.m. his cognitive ability was affected for about 2 hours:  He couldn't remember my name or who he was with.  It didn't last long and I don't know if it was related to the shot or not but decided it was worth reporting in case there is a relationship.
She had minimal sore arm for a couple of hours; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.   A 75-year-old female patient received BNT162b2 (BNT162B2), as dose 1, single (Lot number: EN5318) for covid-19 immunisation. The patient's relevant medical history included: "diabetes" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "recovered", described as "She had minimal sore arm for a couple of hours".  Additional information: The patient stated she was a fan of Pfizer. The first vaccine that was available to caller was Pfizer and she stuck with that. She had minimal sore arm for a couple of hours for side effect. She was happy with it. She doesn't want to be a complainer.
3 days post 2nd vax developed a maculopapular rash; No adverse experience w/1st dose;
Complaint of dizziness, shortness of breath, and then some difficulty swallowing. No oral edema noted. Treated with nasal prong oxygen, IV solu-medrol, and IV epinephrine, with symptoms resolved.  12/1/09 Medical records received for DOS 11/14/09 Final DX: Allergic reaction C/O SOB lightheadedness, throat tightness, tachycardia  s/p vaccine. D/C to home stable.
3/16/10 Patient called day after GARDASIL injection 3 hrs. after injection, shopping for groceries and felt dizzy, confused. Home that night developed pain, neck, stomach, legs, chest. Gone by 3/17/10. Patient felt tired 3/16/10. At work now 3/17/10.
9:25 - TWINRIX + TDAP given  9:35 - passed out in lobby - unconscious 10 min sustained 1-1 1/2 inch laceration to back of head in fall
I would wake up with leg cramps and back pain and was unable to really move around much. So, I went to the doctor.  They gave me steroid shots and recommended I take what I normally take for headaches which is ibuprofen. The main issues were the back pain and headaches. I've always had back pain, but it subsided for a while but then after the vaccine it came back.
I felt fatigued for 2 days after the vaccination and then no issues until around day 16. I developed chills, fever, headache, neck aches, malaise and extreme fatigue that lasted 12 days and then resolved for the most part except still experiencing some fatigue. I was concerned because I was expecting side effect shortly after the vaccine however the symptoms were very much delayed. Although I have been very isolated before and after the vaccine I grew concerned I may have been exposed to COVID though highly unlikely and got a PCR covid test which came back negative
Arm was sore and red after vaccine on first day. Patient reports that arm is now hot to touch but soreness has gone away.
The COVID arm was large, oval at the injection site with severe itching. I had vitiligo since 2016, which it has been stable until I received the first and continuing with the ongoing shots at well. Once receiving the first injection, the vitiligo has been out of control. In May 2022, I tested positive for COVID-19, and my vitiligo was worsened more after as well and I believe it's still getting worst. I had fatigue after COVID also, I now have joint more after having COVID-19 and its seeming to increase in pain.
Burning and itching with raised fine rash on cheeks, extended down arms, chest and abd with large whelps on lower back.
About 2 weeks after getting the first vaccine shot, the skin on my index finger of my right hand was extremely itchy. I scratched it and thought it was a bite or something. The itchy rash is all over my right hand, one spot on my left hand, and on both of my feet. While I was looking up what the rash could be, nothing really resembled the rash. Then today I saw articles about ?COVID toe?. This COVID toe rash matches my rash exactly by look and feel. I was worried I had COVID so I got a rapid test today. The results came up negative but I did have the antibodies. I believe I got this ?COVID toe? rash from the vaccine. The rash red raised patches with some purple and it is very itchy and has a burning sensation.
This spontaneous report was received from a healthcare worker refers to a patient of unknown age. On 26-AUG-2015, the patient was inadvertently vaccinated with a dose of PROQUAD (Merck) which was expired on 18-AUG-2015. No adverse effects were reported. The outcome of the events were unknown. Additional information has been requested.
Pain started on shoulder and is descending along the arm, moving across the all arm elbow and now reaching the hand; Pain started on shoulder and is descending along the arm, moving across the all arm elbow and now reaching the hand; This spontaneous case was received on 30-Aug-2022 from other non-healthcare professional (consumer) via Agency (reference number SEQW22-02560) and concerned an 80-year-old, male patient.  The patient's concurrent condition included high blood pressure, Non Hodgkin lymphoma and atrial fibrillation. The patient's concomitant medications were not reported.    On 26-Aug-2022, the patient was vaccinated with Fluad Quadrivalent (influenza vaccine inact sag 4v; dose: 0,5 ml, route of administration, anatomical location and indication: not reported). The butch number was not reported.  On 27-Aug-2022, one day after receiving Fluad Quadrivalent, the patient experienced pain that started on shoulder and was descending along the arm, moving across the all arm, elbow and reaching the hand.  At the time of initial reporting, the patient had not recovered from both events since it was reported that it was on going.   The reporter did not provide a causality assessment.  The case was assessed as non-serious.  Company comment: Events pain in extremity and arthralgia are assessed as possibly related to Fluad Quadrivalent due to plausible temporal relationship.; Sender's Comments: Events pain in extremity and arthralgia are assessed as possibly related to Fluad Quadrivalent due to plausible temporal relationship.
pt recv vax & exp rash on the leg;event resolved w/in 24hr;
The right arm and hand, where the shot was given became swollen By the following month, this had moved to my body joints and muscles becoming achy and stiff. The symptoms were just like the flu, but they did not go away.
having numbness in his right toe; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 47 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 01Jun2021 14:30 (Lot number: EW0178) at the age of 46 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "slightly high blood pressure" (unspecified if ongoing), notes: no major condition may be just slightly high blood pressure. Concomitant medication(s) included: PROPECIA. The following information was reported: HYPOAESTHESIA (non-serious) with onset Jun2021, outcome "unknown", described as "having numbness in his right toe".  Additional information: Patient does not receive any other vaccine within 4 weeks prior to COVID-19 vaccine. Patient mentioned that he has numbness in his right toe and he got his first shot 3 weeks ago on 01Jun2021 and the second shot is scheduled in a couple of days.  No follow-up attempts are possible. No further information is expected.
4 days after receiving my second dose of Phizer I developed an itchy bump on my right shoulder, 06/12/2021. By 06/15/2021 the bump spread into a rash so I went to my primary care physician. My PCP diagnosed me with shingles, and stated that I was the second case of shingles he had seen in the day, which was odd to him. When I left the doctors office I called my father to tell him about my shingles. He informed me my grandmother also just recovered from a case of shingles. When I got home I searched ?shingles? on Twitter and searched the latest tweets to see if it was common. I came across many tweets of people reporting shingles/chickenpox after their covid vaccination. I called my father to see if my grandmother who just recovered from shingles had been vaccinated. He confirmed she broke out in shingles after her second covid vaccination also.
This spontaneous report as received from a pharmacist refers to a newborn male patient of unknown age. On 02-NOV-2012 at 20:02, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot # were involved and the lot # were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot # the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Narrative:  67yo male patient died at HOSPITAL on Oct 11,2021@07:00. Pt with the following comorbidities: Heart Disease Hyperlipidemia Hypothyroidism Diabetes Type II Sleep Apnea Arthritis Lumbar spine DDD dx during specific time Left ankle pain/ ankle fractures during specific time Pt had received covid vaccines on 3/23/21 & 2/23/21. This death is likely not related to the vaccinations due to comorbidities, age, and length of time from vaccine administration.
Administered shingrix via gluteus maximus instead of deltoid; This case was reported by a other health professional via call center representative and described the occurrence of intramuscular formulation administered by other route in a 69-year-old male patient who received Herpes zoster (Shingrix) (batch number A725Y, expiry date 30th May 2023) for prophylaxis.   On 21st February 2022, the patient received Shingrix. On 21st February 2022, unknown after receiving Shingrix, the patient experienced intramuscular formulation administered by other route. On an unknown date, the outcome of the intramuscular formulation administered by other route was unknown.  Additional details were provided as follows: The patient received Shingrix via gluteus maximus instead of deltoid, which led to intramuscular formulation administered by other route. The reporter consented to follow up.  The Vaccine Administration Facility is the same as Primary Reporter.
Vaccinated with Moderna on 1/30/21 and 2/27/21.  Symptom onset 6/1/21 with cough, runny nose, shortness of breath, nasal congestion and pain/pressure in the chest.  Patient does have a history of lung and sinus infections.  Sample sent for genomic sequencing.
pt recv vax 7JAN96 & devel an inj site rxn, characterized by pain & redness (pain that feels like it goes to the home) & pain, numbness, & tingling in lt hand;inj given using a 3cc syringe & 23 G needle;
No symptoms during the mandatory 15 minute post-vaccine period in clinic waiting area. Experienced mild fatigue/general tiredness approximately 6-7 hours after receiving vaccine (given 12:35 pm). Full body chills/muscle spasms then occurred around 9:30 pm and lasted about 40 minutes.
Arm very sore to move, slight swelling. Went to the Dr on 10/31/2013 due to arm very sore to move and affecting my activities of daily living. Painful to use Deltoid muscle at all (9/10 on the pain scale). I was given steroids which didn't help at all. On 11/13/2013 I am going to the Dr again as there has been absolutely NO IMPROVEMENT in the pain, it is constant (5/10) and with movement, the pain shoots up my neck and down my arm (9/10). It's been 43 days since the vaccine.
Patient was given an influenza vaccine at approx 10:00 a.m on 10/6/10. She started feeling dizzy, clammy/sweating, and rapid heart beat around 4:00 p.m on 10/6/10. She was give 2 tables spoons of BENADRYL and vitals were monitored.
This case was reported by a healthcare professional and described the occurrence of maculopapular rash in a 61 year old male subject who was vaccinated with FluLaval for prophylaxis. The subject's medical history included "lung issues." The subject had received influenza virus vaccine in previous years with no subsequent adverse events. Concurrent medications included Effexor, Albuterol, Imitrex, Roxicodone, Ultram, Flonase, Claritin, Adodart and Nexium. On 16 November 2006 the subject received a dose of FluLaval in the left arm. The healthcare professional reported that on 16 November 2006, the subject also initiated therapy with "a new lung medication." The name of the lung medication was not reported. On 17 November 2006, 1 day after vaccination with FluLaval, the subject experienced maculopapular rash and urticaria. The rash was described as "diffuse in location." The subject was seen at a physician's office and was treated with Benadryl and Prednisone. At the time of initial reporting, 21 November 2006, the events were ongoing. The healthcare professional considered the events were possibly related to vaccination with FluLaval. Follow up received on 19 December 2006 indicated that the subject started on Asmanex on 10 November 2006 and she considered that the events could have been associated with this medication. The events resolved on 22 November 2006.
rash on her right wrist; This is a spontaneous report from a contactable consumer (patient). A 29-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: EW0150), via an unspecified route of administration, administered in the left arm on 01Apr2021 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that a few days after the first dose on 01Apr2021 the patient started noticing a rash on her right wrist. She said "she took the first Dose of Pfizer Covid 19 vaccine on April first and second dose on April 29 and few days after the April the first she started noticing a rash on her right wrist and she had taken injection in her left arm. And she said the rash started to clear up little bit but after she got the second dose it actually started getting more severe and now it has  spread through out her entire body , on her arm ,thighs , legs ,chest, belly So she wanna to report that, her doctor prescribed topical steroid cream and Said it should go away after a few weeks, So we just wanna to get it reported for her, She said its bothers in night, She can't  get a good night rest, its like eczema  ,very itchy and scaling skin, most of the part on her upper body ,on her  upper arm its like red spots itchy it has not manifested on to surface of the skin yet on the arms". The outcome of the event was unknown.
Diarrhea, vomiting, and fever.  Has continued throughout the day.  Lower back pain.
DOSE ONE OF A PFIZER VACCINE WAS GIVEN TO AN 11 YEAR OLD.
Pericarditis, presenting as chest pain.  Symptoms began 10 days after first vaccination for SPV (vaccinia).  Treated with NSAIDs, observation. *This is an interval report--I believe an initial report has been made by initially treating physicians* Information from 60 day follow-up report states: Pain free, fully active including vigorous exercise without limitations. Information received from Medical records states difficulty breathing.
Patient under age 65 administered Fluzone HD in error no adverse event; Related cases: US-SA-2022SA364394, US-SA-2022SA365006, US-SA-2022SA365119, US-SA-2022SA365883.  Initial information received on 31-Aug-2022 regarding an unsolicited valid  non-serious case received from a pharmacist.  This case involves a 41 years old female patient who was administered influenza quadrival A-B high dose HV vaccine [Fluzone High-Dose Quadrivalent] in error no adverse event. Patient is under age 65.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.    On 30-Aug-2022, the patient received a 0.7 ml dose of suspect influenza quadrival A-B high dose HV vaccine (formulation, strength: unknown) (lot UJN04AA, 30-Jun-2023) via intramuscular route in the deltoid NOS for immunization patient under age 65 administered fluzone hd in error no adverse event (product administered to patient of inappropriate age) (latency; Same day). Nurse reports that yesterday, they held an Employee Health Clinic and administered flu vaccines. She states that there was a "communication error" between staff, complicated by a failure to perform "triple checks". This resulted in 5 employees receiving FLUZONE HIGH-DOSE. No other vaccines were administered. QUADRIVALENT vaccine, though they were < 65 years-old.  Action taken : not applicable.  Outcome : Unknown.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments:  US-SA-2022SA365119:01258919
Received vaccine on 10-6-11.  Presented to hospital at 06:30 am 10-7-11 in respiratory distress with angioedema of tongue and mouth.  Emergency tracheostomy done.  Patient had also just started taking linsinopril.  Physician stated that the linsinopril could have caused the reaction.  Patient has received the influenza vaccine in past with no reaction.
Reddened area hot to touch (right deltoid), approximately 3 inches in diameter noticed by mother 11:00 this AM. Patient evaluated by Dr. and given home care instructions..cool compresses, Benadryl for itching and call if worsens.
Acute onset left 3rd nerve palsy. (+) fever (Tmax 103). Fever 24 hrs after vaccine. 3rd nerve palsy 48 hrs after vaccine.
This spontaneous report was received from a nurse referring to a patient of unknown age and gender. Patient's concurrent conditions, medical history and concomitant medications were not provided. On 13-OCT-2021 the patient was vaccinated with a Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live recombinant human albumin (rHA) (M-M-RVAXPRO) however reporter was unsure about which lot number administered to patient (Lot T000890 with expiration date reported 08-JAN-2022 and Lot T010650 with expiration date reported 26-MAR-2022 (dose, strength, frequency, route of administration and anatomical location were not provided) for prophylaxis, which was improperly stored (product storage error). The temperature of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-RVAXPRO) was stored had been above was 46F (49.6F) for 2 hours 21 minutes for lot T000890 and was 46F (56.1F) for 3 hours 33 minutes for Lot T010650. No additional adverse effect was reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2112USA000049: US-009507513-2112USA000033: US-009507513-2112USA000051.